Marta Weinstock Selected Research

Marta Weinstock Research Topics

Disease

9	Alzheimer Disease (Alzheimer's Disease) 10/2019 - 03/2002
5	Inflammation (Inflammations) 01/2020 - 10/2008
3	Dementia (Dementias) 10/2019 - 03/2002
3	Colitis 12/2016 - 01/2013
2	Cognitive Dysfunction 10/2019 - 06/2012
2	Ulcerative Colitis 01/2017 - 01/2013
2	Body Weight (Weight, Body) 01/2017 - 12/2016
2	Memory Disorders (Memory Loss) 03/2013 - 03/2007
2	Gliosis 06/2011 - 03/2007
2	Birth Weight (Birth Weights) 01/2010 - 07/2005
2	Neuroblastoma 05/2003 - 10/2002
1	Liver Diseases (Liver Disease) 10/2021
1	Chronic Renal Insufficiency 01/2020
1	Obesity 01/2020
1	Hyperglycemia 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Atrophy 10/2019
1	Acute Liver Failure (Fulminant Hepatic Failure) 10/2017
1	Schizophrenia (Dementia Praecox) 02/2017
1	Weight Loss (Weight Reduction) 01/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2016
1	Depressive Disorder (Melancholia) 05/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2014
1	Ulcer 01/2013
1	Disease Progression 06/2011
1	Neuroinflammatory Diseases 10/2008
1	Premature Obstetric Labor (Premature Labor) 07/2005
1	Parkinson Disease (Parkinson's Disease) 06/2003
1	Ischemia 06/2003
1	Lewy Body Disease (Lewy Body Dementia) 05/2003

Drug/Important Bio-Agent (IBA)

8	(N-propargyl-(3R) aminoindan-5-yl)-ethyl methyl carbamateIBA 10/2019 - 03/2002
6	Cholinesterases (Cholinesterase)IBA 01/2013 - 10/2002
5	indolineIBA 01/2020 - 05/2014
4	CarbamatesIBA 01/2017 - 05/2003
4	Cholinergic Agents (Cholinergics)IBA 01/2013 - 06/2003
4	Monoamine Oxidase (MAO)IBA 06/2011 - 04/2002
4	Pharmaceutical PreparationsIBA 03/2007 - 03/2002
4	rasagiline (Azilect)FDA Link 05/2003 - 04/2002
3	AN1284IBA 10/2021 - 10/2017
3	AntioxidantsIBA 10/2018 - 12/2012
3	Rivastigmine (Exelon)FDA LinkGeneric 01/2017 - 10/2008
3	2,4-dinitrofluorobenzene sulfonic acidIBA 12/2016 - 01/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 12/2016
2	Peroxidase (Myeloperoxidase)IBA 01/2017 - 12/2016
2	Dextrans (Dextran)FDA Link 01/2017 - 01/2013
2	Sulfonic AcidsIBA 12/2016 - 01/2013
2	CytokinesIBA 12/2016 - 06/2012
2	Acetylcholine (Acetylcholine Chloride)FDA Link 03/2013 - 01/2013
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 12/2012 - 10/2008
2	Hormones (Hormone)IBA 01/2010 - 07/2005
2	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 03/2007 - 06/2003
2	methyl carbamateIBA 05/2003 - 10/2002
2	Amyloid (Amyloid Fibrils)IBA 05/2003 - 10/2002
2	N-propargylIBA 05/2003 - 04/2002
2	(N-propargyl-(3R) and (3S) aminoindan-5-yl)-ethyl methyl carbamateIBA 05/2003 - 10/2002
2	Proteins (Proteins, Gene)FDA Link 05/2003 - 10/2002
1	CreatinineIBA 01/2020
1	AlbuminsIBA 01/2020
1	Apolipoproteins E (ApoE)IBA 10/2019
1	GalactosamineIBA 10/2017
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 10/2017
1	LipopolysaccharidesIBA 10/2017
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2017
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2017
1	SolutionsIBA 01/2017
1	2,4-dinitrobenzeneIBA 12/2016
1	Benzene (Benzole)IBA 12/2016
1	Corticotropin-Releasing HormoneIBA 05/2015
1	Organophosphonates (Phosphonates)IBA 01/2015
1	furanIBA 01/2015
1	cyclopentenoneIBA 01/2015
1	EstersIBA 05/2014
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2013
1	SodiumIBA 01/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2012
1	ButyrylcholinesteraseIBA 06/2011
1	AcetylcholinesteraseIBA 06/2011
1	3-nitrotyrosineIBA 03/2007
1	Streptozocin (Streptozotocin)FDA Link 03/2007
1	Methionine EnkephalinIBA 07/2005
1	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2005
1	propargylamineIBA 06/2003
1	Peroxynitrous Acid (Peroxynitrite)IBA 06/2003
1	phenethylamineIBA 11/2002
1	Selegiline (E250)FDA LinkGeneric 04/2002
1	Cholinergic Antagonists (Anticholinergics)IBA 03/2002
1	Antidepressive Agents (Antidepressants)IBA 03/2002

Therapy/Procedure

1	Rectal Administration 01/2013
1	Immunomodulation 10/2008
1	Oral Administration 03/2007